Related Experiment Video
Updated: Jul 24, 2025

Author Spotlight: Unveiling Mitochondrial Contact Sites and Architectural Insights
Published on: June 16, 2023
Mitochondrial MICOS complex genes, implicated in hypoplastic left heart syndrome, maintain cardiac contractility and
Katja Birker1, Shuchao Ge1, Natalie J Kirkland2
1Development, Aging and Regeneration Program, Center for Genetic Disorders & Aging Research, Sanford Burnham Prebys Medical Discovery Institute, San Diego, United States.
Insights
Genetic variants in CHCHD3/6 and interacting genes contribute to hypoplastic left heart syndrome (HLHS). This study identifies novel genetic factors and pathways implicated in this severe congenital heart defect (CHD).
Area of Science:
- Genetics and Molecular Biology
- Cardiovascular Research
- Developmental Biology
Background:
- Hypoplastic left heart syndrome (HLHS) is a severe congenital heart defect (CHD) with limited understanding of its genetic basis.
- Existing knowledge suggests an oligogenic etiology, but specific genes and pathogenic mechanisms remain largely unknown.
- Whole genome sequencing (WGS) offers a powerful approach to uncover genetic underpinnings of complex diseases like HLHS.
Purpose of the Study:
- To identify novel candidate genes and understand genetic interactions contributing to HLHS.
- To functionally validate candidate genes using a *Drosophila* heart model.
- To explore the role of mitochondrial function and diverse genetic pathways in HLHS pathogenesis.
Main Methods:
- Whole genome sequencing (WGS) of 183 HLHS patient-parent trios.
- Bioinformatic analysis to prioritize candidate genes with rare, damaging variants.
- Functional testing in *Drosophila* using cardiac-specific knockdown (KD) and genetic interaction studies.
Main Results:
- Cardiac-specific KD of *dCHCHD3/6* in flies caused severe heart defects, reduced ATP, and mitochondrial dysfunction.
- Rare damaging variants in *CHCHD3* or *CHCHD6* were identified in five additional HLHS patients.
- Synergistic heart defects observed when *CHCHD3/6* KD was combined with KD of *Cdk12*, *RNF149*, or *SPTBN1*, indicating involvement of diverse pathways.
Conclusions:
- The mitochondrial MICOS complex subunit *CHCHD3/6* is a novel candidate gene for HLHS.
- HLHS likely results from an oligogenic basis involving interactions between multiple genes and pathways.
- Further research into novel genes and genetic interactions will enhance understanding of HLHS and other CHDs.
Abstract:
Hypoplastic left heart syndrome (HLHS) is a severe congenital heart disease (CHD) with a likely oligogenic etiology, but our understanding of the genetic complexities and pathogenic mechanisms leading to HLHS is limited. We performed whole genome sequencing (WGS) on 183 HLHS patient-parent trios to identify candidate genes, which were functionally tested in the Drosophila heart model. Bioinformatic analysis of WGS data from an index family of a HLHS proband born to consanguineous parents prioritized 9 candidate genes with rare, predicted damaging homozygous variants. Of them, cardiac-specific knockdown (KD) of mitochondrial MICOS complex subunit dCHCHD3/6 resulted in drastically compromised heart contractility, diminished levels of sarcomeric actin and myosin, reduced cardiac ATP levels, and mitochondrial fission-fusion defects. These defects were similar to those inflicted by cardiac KD of ATP synthase subunits of the electron transport chain (ETC), consistent with the MICOS complex's role in maintaining cristae morphology and ETC assembly. Five additional HLHS probands harbored rare, predicted damaging variants in CHCHD3 or CHCHD6. Hypothesizing an oligogenic basis for HLHS, we tested 60 additional prioritized candidate genes from these patients for genetic interactions with CHCHD3/6 in sensitized fly hearts. Moderate KD of CHCHD3/6 in combination with Cdk12 (activator of RNA polymerase II), RNF149 (goliath, E3 ubiquitin ligase), or SPTBN1 (β-Spectrin, scaffolding protein) caused synergistic heart defects, suggesting the likely involvement of diverse pathways in HLHS. Further elucidation of novel candidate genes and genetic interactions of potentially disease-contributing pathways is expected to lead to a better understanding of HLHS and other CHDs.
More Related Videos
11:26Analyzing Oxygen Consumption Rate in Primary Cultured Mouse Neonatal Cardiomyocytes Using an Extracellular Flux Analyzer
Published on: February 13, 2019
03:45Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model
Published on: August 8, 2022
Related Concept Videos
The Inner Mitochondrial Membrane
Cardiomyopathy III: Hypertrophic Cardiomyopathy
The Role of Actin and Myosin in Non-muscle Cells
Pathophysiology of Cardiac Performance
The Supercomplexes in the Crista Membrane
Specialized Characteristics of Cardiac Muscles
Cardiac muscle cells are smaller than skeletal muscles, averaging 10–20 mm in diameter and 50–100 mm in length. However, they have large energy demands for continuous contraction and relaxation. This energy is almost exclusively derived from aerobic metabolism of energy...